Immune checkpoint inhibitorsmelanomanon-small cell lungStomach cancerLancet OncolImmune Checkpoint InhibitorsWorld Bankkidneykidney cancer
…Background Immune checkpoint inhibitors (ICIs) have redefined treatment for high-burden cancers such as…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,221–2,280 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Epidural spinal cord stimulation1Erector spinae blocks1Erector spinae plane blocks1European guidelines1Ewing-like chemotherapy1ExCR1Exercise interventions1Exercise loading programme1Exercise training1Exercise-based physiotherapy1Exploratory laparotomy1Exposure therapy1Extracorporeal support1Eyelash extension1FB-BAL1FDA-approved disease-modifying therapies1FRONT block1Fetal aortic valvuloplasty1Fibrinolysis therapy1Flavonoid supplementation1Flexible Assertive Community Treatment1Flexible endoscopic septotomy1Flow diverter treatment1Flow-augmentation bypass1Flow-diverting stents1Focal resection1Focused shockwave1Fontan operation1Fontan palliation surgery1Fractional head rotation1Frontal sinus cranialization1GDFT1GDMT-withdrawn1GI bleeding management1GIBs1GKRS1GLP-1 agonist injections1GPC3-directed CAR-T therapy1GPi-DBS1GR-C1GalNAc conjugation1Gamma-Knife Radiosurgery1Gastrointestinal decompression1Gender affirming care1Gender-affirming hormone therapy121Gene and cell therapies1Genetically modified cell-based therapies1Greater occipital nerve blocks1Group interpersonal therapy1Gut microbiota-targeted therapy1H. pylori eradication1H. pylori treatment1HARMONY1HASO1HBOT1HBV vaccination1HCV treatment1HDRBT1HER2-targeted therapy1HER2-targeting ADCs1
Articles mentioning treatments
7,227 articles · page 489 of 603Neoadjuvant strategiesnivolumabcabozantinibimCORE Grant 142583Hepatocellular carcinoma (HCC)Johns HopkinsEthicsNCT03299946
…mary liver cancers and is frequently unresectable at diagnosis. Neoadjuvant strategies aimed at downsizing tumors may enable curative resection in the…
Adoptive cell therapiesmelanomacyclophosphamideneuroblastomaNBcolorectalC57BL/6 mice
…Background Adoptive cell therapies, including T and natural killer T (NKT) cells expressing GD2-sp…
anti-PD-1 therapyNSCLCnon-small cell lung cancerCheckpoint inhibitors
…models in mice to identify targets which restore sensitivity to anti-PD-1 therapy.Results Knockout of MGAT1, an enzyme critical for maturation of…
ICBrenal clear cell carcinomaCCL20renal cell carcinomaccRCCNature Biotechnologyadvanced clear cell renal cell carcinomaOncology Research Exchange Network
… first to propose 14q- coupled with FTL3 can positively predict ICB response in ccRCC.References Matthew Kyle L, Jason Z, Rajan G, …
76.0%
immune checkpoint blockadeIFN-β
…y may potentiate durable anti-tumor immunity when combined with immune checkpoint blockade. Utilizing high throughput CRISPR-Cas9 screening assays, our gr…
tumor treatmentTarlatamabTalquetamabDLL3 TCE
…gen (TAA) on cancer cells, have demonstrated great potential in tumor treatment. Due to the complex mechanism of TCE molecules, advanced models…
immunotherapyprostate cancercolorectal cancerlung cancerbreast cancerlymphomamelanomaHiPlex Pro
…mor-immune interface and identify functional states relevant to immunotherapy and disease progression.References Ferri-Borgogno S, et al. Mol…
HER2-targeting ADCsbreast cancerstrastuzumab emtansinenon-small cell lung cancersChampions OncologystaurosporineHER2-driven cancers
…SO) to establish Z′-factor metrics. Organoids were treated with HER2-targeting ADCs (e.g., trastuzumab emtansine), payload-only controls, and isoty…
immunotherapiesuterine Leiomyosarcoma
…are ideal targets for effective anti-tumor immune responses and immunotherapies; however, for their clinical application, more accurate and eff…
immunotherapyLung cancerNSCLC
…s of the tumor microenvironment (TME) predictive of response to immunotherapy. Using a combination of protein- and RNA-based -omic technologi…
immunotherapyUniversity of PittsburghNSCLCsolid tumors
…that could be used to modulate TLS in solid tumors for improved immunotherapy response.Ethics Approval This study was approved by the Univers…